nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—Furosemide—dilated cardiomyopathy	0.374	1	CbGbCtD
Auranofin—PRDX5—Detoxification of Reactive Oxygen Species—SOD2—dilated cardiomyopathy	0.036	0.113	CbGpPWpGaD
Auranofin—PRDX5—Detoxification of Reactive Oxygen Species—GPX1—dilated cardiomyopathy	0.0344	0.108	CbGpPWpGaD
Auranofin—PRDX5—cardiac ventricle—dilated cardiomyopathy	0.0317	0.265	CbGeAlD
Auranofin—PRDX5—myocardium—dilated cardiomyopathy	0.0298	0.249	CbGeAlD
Auranofin—PRDX5—heart—dilated cardiomyopathy	0.0208	0.174	CbGeAlD
Auranofin—PRDX5—cardiac atrium—dilated cardiomyopathy	0.0178	0.149	CbGeAlD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—BAG3—dilated cardiomyopathy	0.0147	0.0462	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.014	0.044	CbGpPWpGaD
Auranofin—PRDX5—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.0134	0.042	CbGpPWpGaD
Auranofin—IKBKB—heart—dilated cardiomyopathy	0.0123	0.103	CbGeAlD
Auranofin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00822	0.0436	CcSEcCtD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—NPPB—dilated cardiomyopathy	0.0072	0.0226	CbGpPWpGaD
Auranofin—ALB—heart—dilated cardiomyopathy	0.0072	0.0601	CbGeAlD
Auranofin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0069	0.0366	CcSEcCtD
Auranofin—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00676	0.0358	CcSEcCtD
Auranofin—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00614	0.0326	CcSEcCtD
Auranofin—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00606	0.0321	CcSEcCtD
Auranofin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00587	0.0311	CcSEcCtD
Auranofin—PRDX5—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.00581	0.0183	CbGpPWpGaD
Auranofin—PRDX5—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.00555	0.0174	CbGpPWpGaD
Auranofin—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00554	0.0294	CcSEcCtD
Auranofin—PRDX5—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00531	0.0167	CbGpPWpGaD
Auranofin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00518	0.0274	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—PSEN1—dilated cardiomyopathy	0.00491	0.0154	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—NPPA—dilated cardiomyopathy	0.00468	0.0147	CbGpPWpGaD
Auranofin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00462	0.0245	CcSEcCtD
Auranofin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00447	0.0237	CcSEcCtD
Auranofin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00376	0.0199	CcSEcCtD
Auranofin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00375	0.0199	CcSEcCtD
Auranofin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00348	0.0185	CcSEcCtD
Auranofin—IKBKB—FAS (CD95) signaling pathway—FASLG—dilated cardiomyopathy	0.00346	0.0109	CbGpPWpGaD
Auranofin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00338	0.0179	CcSEcCtD
Auranofin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00335	0.0178	CcSEcCtD
Auranofin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00334	0.0177	CcSEcCtD
Auranofin—IKBKB—FAS (CD95) signaling pathway—FAS—dilated cardiomyopathy	0.00334	0.0105	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—NPPA—dilated cardiomyopathy	0.00333	0.0105	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—PSEN2—dilated cardiomyopathy	0.00329	0.0103	CbGpPWpGaD
Auranofin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00323	0.0171	CcSEcCtD
Auranofin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00322	0.0171	CcSEcCtD
Auranofin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00317	0.0168	CcSEcCtD
Auranofin—Flatulence—Furosemide—dilated cardiomyopathy	0.0031	0.0164	CcSEcCtD
Auranofin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00308	0.0163	CcSEcCtD
Auranofin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00306	0.0163	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00301	0.00947	CbGpPWpGaD
Auranofin—Vomiting—Spironolactone—dilated cardiomyopathy	0.003	0.0159	CcSEcCtD
Auranofin—ALB—Platelet degranulation—TTN—dilated cardiomyopathy	0.003	0.00943	CbGpPWpGaD
Auranofin—Rash—Spironolactone—dilated cardiomyopathy	0.00298	0.0158	CcSEcCtD
Auranofin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00297	0.0158	CcSEcCtD
Auranofin—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00296	0.0157	CcSEcCtD
Auranofin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00294	0.0156	CcSEcCtD
Auranofin—Anaemia—Furosemide—dilated cardiomyopathy	0.00291	0.0154	CcSEcCtD
Auranofin—IKBKB—NOD pathway—RAC1—dilated cardiomyopathy	0.00288	0.00906	CbGpPWpGaD
Auranofin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00288	0.0153	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00286	0.00898	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—SOD2—dilated cardiomyopathy	0.00285	0.00897	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00283	0.00888	CbGpPWpGaD
Auranofin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00282	0.0149	CcSEcCtD
Auranofin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00282	0.0149	CcSEcCtD
Auranofin—Nausea—Spironolactone—dilated cardiomyopathy	0.0028	0.0149	CcSEcCtD
Auranofin—IKBKB—FoxO family signaling—FASLG—dilated cardiomyopathy	0.00264	0.00831	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.0026	0.00817	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00256	0.00804	CbGpPWpGaD
Auranofin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00251	0.0133	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00248	0.00779	CbGpPWpGaD
Auranofin—Anorexia—Furosemide—dilated cardiomyopathy	0.00245	0.013	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—ITGB1—dilated cardiomyopathy	0.00242	0.00761	CbGpPWpGaD
Auranofin—Alopecia—Lisinopril—dilated cardiomyopathy	0.0024	0.0127	CcSEcCtD
Auranofin—IKBKB—Validated transcriptional targets of TAp63 isoforms—FAS—dilated cardiomyopathy	0.00236	0.00741	CbGpPWpGaD
Auranofin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00233	0.0123	CcSEcCtD
Auranofin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00231	0.0123	CcSEcCtD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00228	0.00716	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—RAC1—dilated cardiomyopathy	0.00228	0.00716	CbGpPWpGaD
Auranofin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00223	0.0118	CcSEcCtD
Auranofin—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.00221	0.00695	CbGpPWpGaD
Auranofin—Constipation—Furosemide—dilated cardiomyopathy	0.0022	0.0116	CcSEcCtD
Auranofin—Anaemia—Lisinopril—dilated cardiomyopathy	0.00218	0.0116	CcSEcCtD
Auranofin—IKBKB—mTOR signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00218	0.00685	CbGpPWpGaD
Auranofin—Angioedema—Lisinopril—dilated cardiomyopathy	0.00216	0.0114	CcSEcCtD
Auranofin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00211	0.0112	CcSEcCtD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00211	0.00662	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0021	0.0111	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—RAF1—dilated cardiomyopathy	0.00207	0.00652	CbGpPWpGaD
Auranofin—IKBKB—Type II diabetes mellitus—TNF—dilated cardiomyopathy	0.00205	0.00645	CbGpPWpGaD
Auranofin—Urticaria—Furosemide—dilated cardiomyopathy	0.00204	0.0108	CcSEcCtD
Auranofin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00203	0.0108	CcSEcCtD
Auranofin—IKBKB—Canonical NF-kappaB pathway—TNF—dilated cardiomyopathy	0.00198	0.00623	CbGpPWpGaD
Auranofin—IKBKB—EBV LMP1 signaling—TNF—dilated cardiomyopathy	0.00198	0.00623	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—RAC1—dilated cardiomyopathy	0.00197	0.00619	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00197	0.00618	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—RAC1—dilated cardiomyopathy	0.00194	0.00611	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—RAC1—dilated cardiomyopathy	0.00194	0.00611	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—RAC1—dilated cardiomyopathy	0.0019	0.00597	CbGpPWpGaD
Auranofin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00189	0.01	CcSEcCtD
Auranofin—IKBKB—TWEAK Signaling Pathway—RAF1—dilated cardiomyopathy	0.00187	0.00589	CbGpPWpGaD
Auranofin—Anorexia—Lisinopril—dilated cardiomyopathy	0.00184	0.00974	CcSEcCtD
Auranofin—Pruritus—Furosemide—dilated cardiomyopathy	0.00182	0.00963	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—RAF1—dilated cardiomyopathy	0.00181	0.00568	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.00178	0.00559	CbGpPWpGaD
Auranofin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00176	0.00931	CcSEcCtD
Auranofin—IKBKB—Apoptosis—FASLG—dilated cardiomyopathy	0.00172	0.0054	CbGpPWpGaD
Auranofin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.0017	0.00899	CcSEcCtD
Auranofin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00167	0.00888	CcSEcCtD
Auranofin—IKBKB—Apoptosis—FAS—dilated cardiomyopathy	0.00166	0.0052	CbGpPWpGaD
Auranofin—IKBKB—p75 NTR receptor-mediated signalling—RAC1—dilated cardiomyopathy	0.00165	0.0052	CbGpPWpGaD
Auranofin—Constipation—Lisinopril—dilated cardiomyopathy	0.00165	0.00873	CcSEcCtD
Auranofin—Vomiting—Furosemide—dilated cardiomyopathy	0.00163	0.00866	CcSEcCtD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—RAC1—dilated cardiomyopathy	0.00162	0.0051	CbGpPWpGaD
Auranofin—Rash—Furosemide—dilated cardiomyopathy	0.00162	0.00858	CcSEcCtD
Auranofin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00162	0.00858	CcSEcCtD
Auranofin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	0.00162	0.00508	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—FASLG—dilated cardiomyopathy	0.00161	0.00506	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00158	0.00835	CcSEcCtD
Auranofin—IKBKB—MyD88:Mal cascade initiated on plasma membrane—CD36—dilated cardiomyopathy	0.00157	0.00495	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.00157	0.00493	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—FAS—dilated cardiomyopathy	0.00155	0.00488	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AGT—dilated cardiomyopathy	0.00155	0.00488	CbGpPWpGaD
Auranofin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00153	0.00811	CcSEcCtD
Auranofin—Nausea—Furosemide—dilated cardiomyopathy	0.00152	0.00809	CcSEcCtD
Auranofin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00152	0.00807	CcSEcCtD
Auranofin—IKBKB—Cardiac Hypertrophic Response—RAF1—dilated cardiomyopathy	0.00151	0.00475	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.00151	0.00474	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00146	0.00459	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.00145	0.00455	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—RAF1—dilated cardiomyopathy	0.00139	0.00437	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.00139	0.00437	CbGpPWpGaD
Auranofin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00136	0.00723	CcSEcCtD
Auranofin—IKBKB—Activated TLR4 signalling—CD36—dilated cardiomyopathy	0.00136	0.00427	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.00133	0.00418	CbGpPWpGaD
Auranofin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00132	0.00699	CcSEcCtD
Auranofin—IKBKB—mTOR signaling pathway—RAF1—dilated cardiomyopathy	0.00131	0.0041	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.00131	0.0041	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—RAF1—dilated cardiomyopathy	0.00129	0.00405	CbGpPWpGaD
Auranofin—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—dilated cardiomyopathy	0.00129	0.00404	CbGpPWpGaD
Auranofin—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—CD36—dilated cardiomyopathy	0.00128	0.00402	CbGpPWpGaD
Auranofin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00122	0.00649	CcSEcCtD
Auranofin—IKBKB—TWEAK Signaling Pathway—TNF—dilated cardiomyopathy	0.00122	0.00385	CbGpPWpGaD
Auranofin—Rash—Lisinopril—dilated cardiomyopathy	0.00121	0.00644	CcSEcCtD
Auranofin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00121	0.00643	CcSEcCtD
Auranofin—IKBKB—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.00121	0.00381	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00119	0.00374	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.00118	0.0037	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00117	0.00367	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00115	0.00363	CbGpPWpGaD
Auranofin—Nausea—Lisinopril—dilated cardiomyopathy	0.00114	0.00607	CcSEcCtD
Auranofin—IKBKB—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.00114	0.00358	CbGpPWpGaD
Auranofin—IKBKB—TNF receptor signaling pathway —TNF—dilated cardiomyopathy	0.00114	0.00358	CbGpPWpGaD
Auranofin—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00114	0.00357	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00113	0.00356	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00108	0.00341	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.00108	0.00338	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—RPS6KB1—dilated cardiomyopathy	0.00107	0.00337	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00105	0.00332	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.00102	0.0032	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.001	0.00315	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—TNF—dilated cardiomyopathy	0.000986	0.0031	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.000986	0.0031	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00098	0.00308	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—RAC1—dilated cardiomyopathy	0.000969	0.00305	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—RAF1—dilated cardiomyopathy	0.000959	0.00302	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.000951	0.00299	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	0.000947	0.00298	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000944	0.00297	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.000932	0.00293	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.000902	0.00283	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000901	0.00283	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000895	0.00281	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.000894	0.00281	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—dilated cardiomyopathy	0.000884	0.00278	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—RAF1—dilated cardiomyopathy	0.00088	0.00277	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000876	0.00275	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000824	0.00259	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000703	0.00221	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—TNF—dilated cardiomyopathy	0.000703	0.00221	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000699	0.0022	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TTN—dilated cardiomyopathy	0.000686	0.00216	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000654	0.00205	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—RAF1—dilated cardiomyopathy	0.000643	0.00202	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000618	0.00194	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000609	0.00191	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	0.000602	0.00189	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	0.000594	0.00187	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000593	0.00187	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000593	0.00186	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000577	0.00181	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000577	0.00181	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000554	0.00174	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000537	0.00169	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VCL—dilated cardiomyopathy	0.000505	0.00159	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	0.00047	0.00148	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	0.000451	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000426	0.00134	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.000424	0.00133	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00042	0.00132	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000415	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000411	0.00129	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000407	0.00128	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000404	0.00127	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000404	0.00127	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000396	0.00124	CbGpPWpGaD
Auranofin—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	0.00039	0.00123	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—EGFR—dilated cardiomyopathy	0.000376	0.00118	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD36—dilated cardiomyopathy	0.000369	0.00116	CbGpPWpGaD
Auranofin—ALB—Metabolism—TAZ—dilated cardiomyopathy	0.000367	0.00115	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000358	0.00113	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000354	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RAC1—dilated cardiomyopathy	0.000347	0.00109	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000334	0.00105	CbGpPWpGaD
Auranofin—ALB—Metabolism—SDHA—dilated cardiomyopathy	0.000332	0.00104	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000277	0.000871	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000262	0.000825	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00026	0.000818	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	0.000254	0.000798	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITGB1—dilated cardiomyopathy	0.000252	0.000791	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000231	0.000726	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000231	0.000726	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RAF1—dilated cardiomyopathy	0.00023	0.000724	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000221	0.000695	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CD36—dilated cardiomyopathy	0.000216	0.00068	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000215	0.000675	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD36—dilated cardiomyopathy	0.000215	0.000675	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000208	0.000654	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAC1—dilated cardiomyopathy	0.000204	0.000641	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAC1—dilated cardiomyopathy	0.000202	0.000636	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000202	0.000636	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000197	0.000619	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000178	0.000558	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000177	0.000558	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000169	0.00053	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—dilated cardiomyopathy	0.000158	0.000497	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000152	0.000477	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000145	0.000455	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAF1—dilated cardiomyopathy	0.000135	0.000425	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAF1—dilated cardiomyopathy	0.000134	0.000422	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000131	0.000411	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AGT—dilated cardiomyopathy	0.000125	0.000393	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000117	0.000368	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—dilated cardiomyopathy	9.2e-05	0.000289	CbGpPWpGaD
Auranofin—ALB—Metabolism—GPX1—dilated cardiomyopathy	9.01e-05	0.000283	CbGpPWpGaD
Auranofin—ALB—Metabolism—CD36—dilated cardiomyopathy	8.77e-05	0.000276	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAF1—dilated cardiomyopathy	8.67e-05	0.000273	CbGpPWpGaD
Auranofin—ALB—Metabolism—AGT—dilated cardiomyopathy	7.9e-05	0.000248	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—dilated cardiomyopathy	5.95e-05	0.000187	CbGpPWpGaD
